Author:
Wada Noriko,Takahashi Tsuyoshi,Kurokawa Yukinori,Nakajima Kiyokazu,Nishida Toshirou,Koh Masahiro,Akamaru Yusuke,Motoori Masaaki,Kimura Yutaka,Tanaka Koji,Miyazaki Yasuhiro,Makino Tomoki,Yamasaki Makoto,Eguchi Hidetoshi,Doki Yuichiro
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Nishida T, Blay JY, Hirota S, Kitagawa Y, Kang YK. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines. Gastric Cancer. 2016;19:3–14.
2. Yoshikawa K, Shimada M, Kurita N, Sato H, Iwata T, Morimoto S, et al. The efficacy of PET-CT for predicting the malignant potential of gastrointestinal stromal tumors. Surg Today. 2013;43:1162–7.
3. Takahashi T, Serada S, Ako M, Fujimoto M, Miyazaki Y, Nakatsuka R, et al. New findings of kinase switching in gastrointestinal stromal tumor under imatinib using phosphoproteomic analysis. Int J Cancer. 2013;133:2737–43.
4. Nishida T, Doi T, Naito Y. Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumors. Expert Opin Pharmacother. 2014;15:1979–89.
5. Demetri GD, van Oosterom AT, Garrett CR, Blackstein ME, Shah MH, Verweij J, et al. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet. 2006;368:1329–38.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献